The main risk is not whether Rocket Lab has demand; it is whether the company can turn that demand into
medium-lift proof, higher-throughput manufacturing, and better cash generation before valuation patience runs out.
Neutron remains the binding technical and capital gate, while regulation, government budget timing, and any reliability break could slow
backlog conversion and compress the multiple.